While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to eliminate the virus, allowing it to ...

The trial, which focuses on chronic hepatitis B (cHBV), shows potential advancements in treatment options for the disease.

Hepatitis B affects almost 300 million people worldwide ... which reported phase 2 data at the AASLD conference last year, and Arrowhead Pharma’s antisense oligonucleotide ARO-HBV.